Department of Pediatrics, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Department of Psychiatry, Division of Child and Adolescent Psychiatry, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
Pediatr Neurol. 2019 Jul;96:58-63. doi: 10.1016/j.pediatrneurol.2019.03.003. Epub 2019 Mar 13.
Children with tuberous sclerosis complex (TSC), caused by pathogenic variants in TSC1/TSC2, are at risk for intellectual disability. TSC2 pathogenic variants appear to increase the risk, compared with TSC1. However, the effect of TSC2 pathogenic variants on early and specific domains of development hasn't been studied. Using an extensively phenotyped group, we aimed to characterize differences in early intellectual development between genotypes.
The study group (n = 92) included participants with TSC enrolled in a multicenter study involving genetic testing and detailed prospective phenotyping including the Mullen Scales of Early Learning, a validated measure of cognition, language, and motor development in babies and preschool children. Mean T-scores at 24 months for each Mullen Scales of Early Learning domain were calculated for children with, versus without, a TSC2 pathogenic variant. Multivariable linear regression models were used to compare the groups, adjusting for seizures.
T-scores on every Mullen Scales of Early Learning domain were significantly worse in the TSC2 group. Below average composite scores were present in three-fourths of the TSC2 group, compared with one-fourth of those without TSC2. Having a TSC2 pathogenic variant was associated with lower composite Mullen Scales of Early Learning scores, even when corrected for seizures.
In a well-characterized patient population with standardized assessment of multiple aspects of development, we found that having a TSC2 pathogenic variant was associated with significantly lower Mullen Scales of Early Learning scores at age 24 months, independent of seizures. These data suggest that a baby with a TSC2 pathogenic variant is at high risk for significant developmental delays by 24 months.
由 TSC1/TSC2 中的致病变异引起的结节性硬化症(TSC)患儿存在智力障碍风险。与 TSC1 相比,TSC2 致病变异似乎会增加这种风险。然而,尚未研究 TSC2 致病变异对早期和特定发育领域的影响。本研究使用经过广泛表型分析的患者群体,旨在分析基因型之间早期智力发育的差异。
研究组(n=92)包括参与多中心研究的 TSC 患者,该研究涉及基因检测和详细的前瞻性表型分析,包括用于评估婴儿和学龄前儿童认知、语言和运动发育的麦尔登早期学习量表(Mullen Scales of Early Learning),这是一种经过验证的认知、语言和运动发育的测量方法。计算了每个 Mullen Scales of Early Learning 领域在 24 个月时患有和不患有 TSC2 致病变异的儿童的平均 T 分数。使用多变量线性回归模型比较了两组,调整了癫痫发作的影响。
在 TSC2 组中,Mullen Scales of Early Learning 每个领域的 T 评分均明显更差。与没有 TSC2 的患儿相比,TSC2 组中四分之三的患儿存在低于平均水平的综合评分,而仅有四分之一的患儿没有 TSC2。即使在纠正了癫痫发作的情况下,携带 TSC2 致病变异与较低的 Mullen Scales of Early Learning 综合评分相关。
在具有标准化评估多种发育方面的特征良好的患者群体中,我们发现即使在考虑到癫痫发作的情况下,携带 TSC2 致病变异与 24 个月时 Mullen Scales of Early Learning 评分明显降低相关。这些数据表明,携带 TSC2 致病变异的婴儿在 24 个月时存在明显发育迟缓的高风险。